Key result
New adverse outcome pathway framework maps cigarette smoke-induced oxidative stress to plaque progression.
Answers are grounded in this paper and cite their sources.
The proposed AOP framework offers an alternative to animal models for assessing the risk of atherosclerosis progression using preclinical assays and biomarkers.
Adverse outcome pathways (AOPs) have been developed as a risk assessment tool for regulatory applications. These AOPs describe a logical mechanistic sequence of events, starting with a Molecular Initiating Event (MIE), and ultimately leading to a disease outcome via a series of Key Events (KE). The AOP framework provides a system to make predictions and assessments while reducing the need for in vivo assessment. In the absence of epidemiological evidence, assessment of the health effects of a product, chemical or therapy on the progression of atherosclerosis would necessitate long-term animal exposure studies such as the use of the Apolipoprotein E deficient mouse. We followed Organisation for Economic Co-operation and Development (OECD) guidelines to formulate and propose an AOP for atherosclerotic plaque progression, collating the evidence by which cigarette smoke-induced oxidative stress forms a MIE. The downstream pathway includes multiple KEs including the upregulation of proinflammatory mediators, nitric oxide depletion, and endothelial dysfunction. Alterations in these KEs can lead to plaque formation and progression in cardiovascular disease and increase the risk of morbidity and mortality. Identifying preclinical endpoints and clinical biomarkers associated with these KEs provides a framework for in vitro and clinical data, supporting a mechanistic narrative for regulatory assessment. The application of this pathway provides a powerful alternative to animal models through developing preclinical assays and biomarkers for the assessment of atherosclerosis progression risk.
No takes yet. Share an insight, caveat, or question.
Makena et al. (2025) conducted a review in Atherosclerotic plaque progression. Cigarette smoke-induced oxidative stress was evaluated on Atherosclerotic plaque progression. An adverse outcome pathway framework was developed to describe how cigarette smoke-induced oxidative stress leads to atherosclerotic plaque progression, providing an alternative to animal models.
Synapse has enriched 10 related papers. Consider them for comparative context: